IBDEI0ZX ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16560,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,16560,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,16560,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,16561,0)
 ;;=E87.5^^88^850^41
 ;;^UTILITY(U,$J,358.3,16561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16561,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,16561,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,16561,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,16562,0)
 ;;=E83.41^^88^850^42
 ;;^UTILITY(U,$J,358.3,16562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16562,1,3,0)
 ;;=3^Hypermagnesemia
 ;;^UTILITY(U,$J,358.3,16562,1,4,0)
 ;;=4^E83.41
 ;;^UTILITY(U,$J,358.3,16562,2)
 ;;=^5003002
 ;;^UTILITY(U,$J,358.3,16563,0)
 ;;=E87.0^^88^850^43
 ;;^UTILITY(U,$J,358.3,16563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16563,1,3,0)
 ;;=3^Hyperosmolality/Hypernatremia
 ;;^UTILITY(U,$J,358.3,16563,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,16563,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,16564,0)
 ;;=E83.51^^88^850^45
 ;;^UTILITY(U,$J,358.3,16564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16564,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,16564,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,16564,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,16565,0)
 ;;=E58.^^88^850^3
 ;;^UTILITY(U,$J,358.3,16565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16565,1,3,0)
 ;;=3^Calcium Deficiency,Dietary
 ;;^UTILITY(U,$J,358.3,16565,1,4,0)
 ;;=4^E58.
 ;;^UTILITY(U,$J,358.3,16565,2)
 ;;=^5002804
 ;;^UTILITY(U,$J,358.3,16566,0)
 ;;=E11.641^^88^850^23
 ;;^UTILITY(U,$J,358.3,16566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16566,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,16566,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,16566,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,16567,0)
 ;;=E11.649^^88^850^24
 ;;^UTILITY(U,$J,358.3,16567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16567,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,16567,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,16567,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,16568,0)
 ;;=E87.6^^88^850^46
 ;;^UTILITY(U,$J,358.3,16568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16568,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,16568,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,16568,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,16569,0)
 ;;=E83.42^^88^850^47
 ;;^UTILITY(U,$J,358.3,16569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16569,1,3,0)
 ;;=3^Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,16569,1,4,0)
 ;;=4^E83.42
 ;;^UTILITY(U,$J,358.3,16569,2)
 ;;=^5003003
 ;;^UTILITY(U,$J,358.3,16570,0)
 ;;=E87.1^^88^850^44
 ;;^UTILITY(U,$J,358.3,16570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16570,1,3,0)
 ;;=3^Hypo-osmolality/Hyponatremia
 ;;^UTILITY(U,$J,358.3,16570,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,16570,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,16571,0)
 ;;=E03.9^^88^850^48
 ;;^UTILITY(U,$J,358.3,16571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16571,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,16571,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,16571,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,16572,0)
 ;;=E86.1^^88^850^49
 ;;^UTILITY(U,$J,358.3,16572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16572,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,16572,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,16572,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,16573,0)
 ;;=E73.9^^88^850^52
 ;;^UTILITY(U,$J,358.3,16573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16573,1,3,0)
 ;;=3^Lactose Intolerance,Unspec
 ;;^UTILITY(U,$J,358.3,16573,1,4,0)
 ;;=4^E73.9
